Internal Medicine, Rheumatology · Canandaigua, NY
NPI
1811286032
Since 2011
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
3
Medicare group memberships
Hospitals
4
Hospital affiliations
335 Parrish St
Canandaigua, NY, 14424
Phone (585) 486-0901
Groups this clinician bills Medicare through
Medicare paid, 2024
$13K
256 services
Medicare patients, 2024
113
Average age 68
Drug cost, 2024
$4.3M
2,153 prescriptions
Company payments, 2025
$115
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Christopher R Palma was code 99214 (office e&m - established), 95 times for 75 patients. In total Christopher R Palma billed 256 services in 11 codes, and Medicare paid $13K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-07-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 95 | 75 | $64.26 | $6,105 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 92 | 71 | $12.11 | $1,114 |
| 99215 Office E&M - Established | Office | 37 | 28 | $103.39 | $3,825 |
| 99213 Office E&M - Established | Office | 13 | 13 | $38.67 | $503 |
By year: 2022 $20K for 289 services; 2023 $13K for 189 services; 2024 $13K for 256 services.
Medicare prescription drug claims, 2024
In 2024, the drug Christopher R Palma prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 338 prescriptions and refills. In total Christopher R Palma wrote 2,153 Medicare prescriptions that cost $4.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 338 | 887 | 114 | $13K |
| Methotrexate Methotrexate Sodium | 273 | 728 | 114 | $9,093 |
| Prednisone Generic | 273 | 595 | 97 | $2,248 |
| Allopurinol Generic | 80 | 229 | 26 | $1,315 |
| Enbrel Sureclick Etanercept | 74 | 107 | 14 | $754K |
| Humira(Cf) Pen Adalimumab | 66 | 88 | 17 | $654K |
| Actemra Actpen Tocilizumab | 58 | 65 | Under 11 | $263K |
| Alendronate Sodium Generic | 53 | 138 | 19 | $416 |
| Enbrel Etanercept | 53 | 73 | 11 | $500K |
| Methylprednisolone Generic | 52 | 77 | 13 | $1,129 |
| Folic Acid Generic | 52 | 147 | 19 | $459 |
| Xeljanz Xr Tofacitinib Citrate | 43 | 43 | Under 11 | $240K |
| Mycophenolate Mofetil Generic | 43 | 98 | 14 | $12K |
| Celecoxib Generic | 40 | 114 | 18 | $3,184 |
| Colchicine Generic | 32 | 56 | Under 11 | $1,931 |
Brand drugs: - claims; generic drugs: 1,598 claims; opioid claims: 18.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Christopher R Palma $115 ($115 in general payments such as food, travel and fees) from 3 companies. The largest payer was Invivyd Inc with $59.9.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.